guest ::
A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis
; ; ; ; ; ; ; ; ; ; ; ;
In
Journal of controlled release 262, Seiten/Artikel-Nr.:47-57
2017
Online
DOI: 10.18154/RWTH-CONV-222346
DOI: 10.1016/j.jconrel.2017.07.013
URL: http://publications.rwth-aachen.de/record/717046/files/717046.pdf
Einrichtungen
OpenAccess: 
PDF
Dokumenttyp
Journal Article
Format
online, print
Sprache
English
Anmerkung
Peer reviewed article
Externe Identnummern
SCOPUS: SCOPUS:2-s2.0-85025474197
WOS Core Collection: WOS:000411201100006
PubMed: pmid:28700897
Interne Identnummern
RWTH-CONV-222346
Datensatz-ID: 717046
Beteiligte Länder
Germany, Netherlands, USA
; 
; 
; BIOSIS Previews ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF >= 5 ; JCR ; NCBI Molecular Biology Database ; Nationallizenz
; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection
|
The record appears in these collections: |
PDF